Senior investor and corporate finance executive with multi-decade experience in value investing, distressed-asset restructurings and board-level advisory. James J. Karabas has led portfolio management and M&A initiatives across private equity and credit strategies, advising companies on capital structure and operational turnarounds. Known for deploying patient capital, liaising with institutional LPs and driving strategic exits. Holds an advanced business degree.
Senior investor and corporate finance executive with multi-decade experience in value investing, distressed-asset restructurings and board-level advisory. James J. Karabas has led portfolio management and M&A initiatives across private equity and credit strategies, advising companies on capital structure and operational turnarounds. Known for deploying patient capital, liaising with institutional LPs and driving strategic exits. Holds an advanced business degree.
Leverages deep experience in value and distressed-asset investing to deploy patient, event-driven capital aimed at capital structure arbitrage and turnaround value creation. Prioritizes rigorous credit and operational underwriting, active board-level governance, and disciplined downside protection through covenants,-secured claims and restructuring playbooks. Prefers concentrated, mid-market opportunities where strategic operational fixes and M&A optionality create asymmetric returns over multi-year horizons. Maintains LP-aligned reporting, exit-focused planning and a conservative leverage tolerance.
Leverages deep experience in value and distressed-asset investing to deploy patient, event-driven capital aimed at capital structure arbitrage and turnaround value creation. Prioritizes rigorous credit and operational underwriting, active board-level governance, and disciplined downside protection through covenants,-secured claims and restructuring playbooks. Prefers concentrated, mid-market opportunities where strategic operational fixes and M&A optionality create asymmetric returns over multi-year horizons. Maintains LP-aligned reporting, exit-focused planning and a conservative leverage tolerance.
| Trades 2203 | Longs Won 1664/2203 75% | Profit Factor 27.45 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $899,983.33 |
| Average Win $183,926.02 | Best Trade (Aug 14) $27.19M | Sharpe Ratio -11.79 |
| Average Loss -$20,688.22 | Worst Trade (Aug 19) -$744,900.03 | Z-Score 20.31 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 6d | Expectancy $133,863.8 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 50,000 | 45,000 | 40,000 | 35,000 | 30,000 | 25,000 | 20,000 | 15,000 | 10,000 | 5,000 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 140,896 | $27.78M | $43.52M | - | $15.74M | 56.66% | -7.354% |
ABBV AbbVie Inc. | 19,706 | $3.17M | $4.95M | - | $1.77M | 55.91% | -2.513% |
ABT Abbott Laboratories | 31,407 | $3.58M | $3.32M | - | -$259,265.82 | -7.24% | +0.085% |
ACN Accenture plc Class A | 2,647 | $849,620.31 | $439,190.24 | - | -$410,430.07 | -48.31% | +1.611% |
AMAT Applied Materials, Inc. | 415 | $300,096 | $210,683.05 | - | -$89,412.95 | -29.79% | +1.176% |
AMD Advanced Micro Devices, Inc. | 1,219 | $261,061.19 | $580,426.84 | - | $319,365.65 | 122.33% | -1.904% |
AMGN Amgen Inc. | 698 | $239,325.99 | $268,841.68 | - | $29,515.69 | 12.33% | -0.64% |
AMZN Amazon.com Inc | 56,526 | $10.32M | $15.35M | - | $5.03M | 48.72% | +15.321% |
ANET Arista Networks, Inc. | 2,329 | $188,381.67 | $420,035.17 | - | $231,653.5 | 122.97% | +5.456% |
APD Air Products and Chemicals, Inc. | 712 | $208,759 | $209,961.69 | - | $1,202.69 | 0.58% | -1.769% |
APH Amphenol Corporation | 5,520 | $373,468.63 | $443,532 | - | $70,063.37 | 18.76% | +0.551% |
ASCE Allspring SMID Core ETF | 101,143 | $2.92M | $3.45M | - | $529,544.78 | 18.14% | 0.0 |
ASML ASML Holding N.V. New York Registry Shares | 151 | $300,406 | $245,979 | - | -$54,427 | -18.12% | -1.359% |
AVGO Broadcom Inc. | 4,263 | $999,469.25 | $1.66M | - | $660,031.39 | 66.04% | +0.371% |
AVIV Avantis International Large Cap Value ETF | 6,425 | $483,437.58 | $518,561.75 | - | $35,124.17 | 7.27% | -0.567% |
AXP American Express Company | 3,731 | $784,880.67 | $1.25M | - | $469,668.08 | 59.84% | -0.376% |
BA Boeing Company | 1,205 | $245,030.74 | $260,448.7 | - | $15,417.96 | 6.29% | -2.155% |
BAC Bank of America Corporation | 109,755 | $4M | $6.8M | - | $2.8M | 70.18% | +0.356% |
BAI iShares A.I. Innovation and Tech Active ETF | 264,731 | $9.77M | $10.94M | - | $1.17M | 12.02% | +0.633% |
BALI iShares Adaptive Large Cap ETF | 36,783 | $1.19M | $1.26M | - | $66,426.69 | 5.59% | +0.56% |